{"nct_id":"NCT01752634","title":"Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis","status":"COMPLETED","status_verified_date":"2020-04","start_date":"2013-04-14","start_date_type":"ACTUAL","primary_completion_date":"2014-05-12","primary_completion_date_type":"ACTUAL","completion_date":"2019-01-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}